USA - NYSE:CMS - US1258961002 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to CMS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-21 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-15 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-07 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-05-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-29 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-04-25 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-04-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-21 | Jefferies | Maintains | Buy -> Buy |
| 2025-04-14 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-24 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-20 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-02-07 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2024-12-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-11-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-05 | Jefferies | Initiate | Buy |
| 2024-11-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-16 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-15 | Mizuho | Downgrade | Outperform -> Neutral |
| 2024-10-15 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-01 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-09-30 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-09-30 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-16 | Keybanc | Maintains | Overweight -> Overweight |
20 analysts have analysed CMS and the average price target is 77.37 USD. This implies a price increase of 4.04% is expected in the next year compared to the current price of 74.36.
The consensus rating for CMS ENERGY CORP (CMS) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.